Evidence map›Paper›PMID 41909419›Full record

ArticleCureus2026

Malignant Struma Ovarii: A Distinctive and Rare Variant of Ovarian Tumors.

Mohamed Kaakoua, Nada Ebbadi, Meriem Mouharir, Hamza Laabbar, Mohamed Amine Haouane, Moussa Abdoul Aziz Sawadogo, Soukayna Boujmadi, Said Kaddouri, Hassan Qacif, Abdelilah Mouhsine and 3 more

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Mohamed KaakouaDepartment of Medical Oncology, Ibn Sina Military Hospital, Marrakesh, MAR.
Nada EbbadiDepartment of Medical Imaging, Ibn Sina Military Hospital, Marrakesh, MAR.
Meriem MouharirDepartment of Internal Medicine, Ibn Sina Military Hospital, Marrakesh, MAR.
Hamza LaabbarDepartment of Medical Oncology, Ibn Sina Military Hospital, Marrakesh, MAR.
Mohamed Amine HaouaneDepartment of Pathology, Ibn Sina Military Hospital, Marrakesh, MAR.
Moussa Abdoul Aziz SawadogoDepartment of Medical Oncology, Ibn Sina Military Hospital, Marrakesh, MAR.
Soukayna BoujmadiDepartment of Medical Oncology, Ibn Sina Military Hospital, Marrakesh, MAR.
Said KaddouriDepartment of Internal Medicine, Ibn Sina Military Hospital, Marrakesh, MAR.
Hassan QacifDepartment of Internal Medicine, Ibn Sina Military Hospital, Marrakesh, MAR.
Abdelilah MouhsineDepartment of Medical Imaging, Ibn Sina Military Hospital, Marrakesh, MAR.
Mohamed Amine AzamiDepartment of Pathology, Ibn Sina Military Hospital, Marrakesh, MAR.
Ismail EssadiDepartment of Medical Oncology, Ibn Sina Military Hospital, Marrakesh, MAR.
Mohamed ZyaniDepartment of Internal Medicine, Ibn Sina Military Hospital, Marrakesh, MAR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Struma ovarii is a very rare histological entity among ovarian tumors. We report the case of a 35-year-old woman presenting with pelvic pain associated with dysmenorrhea. Radiologic examination revealed a left ovarian mass with no signs of metastasis. The patient underwent surgical treatment, which confirmed the presence of thyroid tissue in the left ovary, suggestive of invasive follicular carcinoma. The aim of this case is to highlight this exceptional histological type, which first requires an appropriate diagnostic strategy to rule out metastatic involvement from a primary thyroid tumor before confirming the diagnosis of struma ovarii.

Indexed as

diagnostic approachfollicular carcinomaovarian tumorsrare casestruma ovarii

Identifiers

PMID41909419
PMCPMC13030076

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.